Business Description
Glycorex Transplantation AB
ISIN : SE0000524530
Share Class Description:
NGM:GTAB B: Class BCompare
Compare
Traded in other countries / regions
GTAB B.Sweden IPO Date
1999-12-28Description
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.31 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -1.96 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.67 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.8 | |||||
| 3-Year EBITDA Growth Rate | -71.7 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.51 | |||||
| 9-Day RSI | 69.3 | |||||
| 14-Day RSI | 62.6 | |||||
| 6-1 Month Momentum % | -34.06 | |||||
| 12-1 Month Momentum % | -78.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.62 | |||||
| Cash Ratio | 1.14 | |||||
| Days Inventory | 702.84 | |||||
| Days Sales Outstanding | 75.74 | |||||
| Days Payable | 382.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | -4.34 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.99 | |||||
| Operating Margin % | -48.86 | |||||
| Net Margin % | -49.54 | |||||
| FCF Margin % | -33.59 | |||||
| ROE % | -22.57 | |||||
| ROA % | -16.99 | |||||
| ROIC % | -22.98 | |||||
| ROC (Joel Greenblatt) % | -87.15 | |||||
| ROCE % | -19.93 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.21 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 3.15 | |||||
| EV-to-EBIT | -4.88 | |||||
| EV-to-EBITDA | -11.36 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-FCF | -6.01 | |||||
| Price-to-Projected-FCF | 2.14 | |||||
| Price-to-Median-PS-Value | 0.41 | |||||
| Price-to-Net-Current-Asset-Value | 11.89 | |||||
| Earnings Yield (Greenblatt) % | -20.49 | |||||
| FCF Yield % | -13.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Glycorex Transplantation AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 31.657 | ||
| EPS (TTM) (kr) | -0.21 | ||
| Beta | 0.49 | ||
| Volatility % | 60.98 | ||
| 14-Day RSI | 62.6 | ||
| 14-Day ATR (kr) | 0.135584 | ||
| 20-Day SMA (kr) | 0.86425 | ||
| 12-1 Month Momentum % | -78.47 | ||
| 52-Week Range (kr) | 0.75 - 4 | ||
| Shares Outstanding (Mil) | 73.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Glycorex Transplantation AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Glycorex Transplantation AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Glycorex Transplantation AB Frequently Asked Questions
What is Glycorex Transplantation AB(NGM:GTAB B)'s stock price today?
The current price of NGM:GTAB B is kr1.07. The 52 week high of NGM:GTAB B is kr4.00 and 52 week low is kr0.75.
When is next earnings date of Glycorex Transplantation AB(NGM:GTAB B)?
The next earnings date of Glycorex Transplantation AB(NGM:GTAB B) is 2024-05-24 Est..
Does Glycorex Transplantation AB(NGM:GTAB B) pay dividends? If so, how much?
Glycorex Transplantation AB(NGM:GTAB B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers